Epsi-gam

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpsi-gam

Drug Alias NameGE-2

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionIgE Fc receptor, alpha-subunit modulatorsLow affinity immunoglobulin gamma Fc region receptor II-b antagonistsImmunoglobulin epsilon Fc receptor antagonists

TargetsIgE Fc receptor, alpha-subunitImmunoglobulin epsilon Fc receptorLow affinity immunoglobulin gamma Fc region receptor II-b

Therapy Area/IndicationsHypersensitivity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTunitas

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTunitas

Active IndicationsN/A

Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A